Birth Control Advertising on Meta, What Gets Approved

Meta names contraception in its own policy text as an allowed category. That surprises brands that expected a fight, and it can also lull them. The written rules for contraception are short, and they come down to three things: who the ad is shown to, what the ad is really about, and what the ad claims.

The rules shape the work long before an ad reaches review. A brief that ignores them produces scripts that have to be rewritten after the edit, which is the most expensive place to find a problem. That is why our birth control ad creative starts from the policy and works forward to the hook, rather than the other way round.

Where Contraception Sits in Meta's Rules

Meta handles birth control inside its Health and Wellness advertising standards, in the section that covers adult products and reproductive health. The allowed examples on that page name contraceptive products, including condoms, and family planning methods, including fertility awareness. Women's reproductive health apps, such as ovulation trackers, are listed as allowed as well.

Allowed does not mean unrestricted. Every ad in this section carries two conditions: an age requirement and a focus requirement. Prescription products add a third layer, because Meta sends prescription reproductive health drugs to a different policy with its own requirements. A telehealth brand that prescribes the pill, the patch or the ring is working under all three at once.

The practical consequence is that a birth control account cannot be run like a general wellness account with a few extra checks. The category rules touch audience settings, creative, copy and advertiser status, and a miss in any one of them produces the same outcome: a rejected ad and a mark against the account.

The Adult Targeting Requirement

Meta's standards say ads that promote sexual and reproductive health products or services must be targeted to people 18 years or older. The rule applies to the whole category. It covers prescription products, non-prescription products, and educational offers that lead into a consultation.

This is the easiest rule to break by accident, because the failure is almost never a decision. It is an ad set duplicated from another campaign that carried a different age range. It is a campaign template built for a different vertical. It is a new media buyer who knows the platform well but does not know this category. None of those look like compliance problems until the ad is rejected.

The fix is procedural. Check the age range at the ad set level every time an ad set is created or duplicated, not once at account setup. If your team uses a launch checklist, the age floor belongs on it as its own line, not folded into a general targeting review.

Prescription contraception adds a second age rule from a separate policy. Meta's Drugs and Pharmaceuticals standards say Meta does not allow prescription drug ads to be targeted to people under 18. The same policy requires online pharmacies and telehealth providers to be actively certified with LegitScript, and limits targeting to eligible countries, listed as the United States, Canada and New Zealand, and only to countries where the advertiser is certified. If certification is still in progress, the brand is not yet eligible to run prescription ads, however clean the creative is. Our breakdown of what LegitScript certification requires covers that process.

The Focus Test

The second condition is about what the ad is actually about. Meta allows sexual and reproductive health ads as long as the focus is on health and not on sexual pleasure or enhancement. The same section separately prohibits ads that promote adult sexual arousal products or services.

Birth control sits close to that line because the product relates to sex even when the ad never mentions it. A reviewer judges the overall impression, not individual words. Copy built around freedom, spontaneity or not worrying in the moment can read as a pleasure focus. So can imagery of couples in bed, lingering romantic framing, or a hook that relies on innuendo, however tastefully it is shot.

Ads that pass keep the frame on health care. The consultation. The prescription. The refill that arrives before the last pack runs out. The conversation with a clinician about a side effect. The total cost. The person on screen is managing her health, not her love life.

That framing is not a compromise. It is closer to why people actually go looking for a new prescriber in the first place: a bad experience with a method, a refill that became a chore, a question nobody had time to answer. Our guide to marketing female Rx telehealth brands covers how those motivations shape positioning across the wider category.

What Tends to Trigger a Rejection

Meta does not publish a rejection list for contraception. What it publishes is the policy text, and the common failures in this category map back to a specific line in it.

The first is an age range below 18 on any ad set, covered above. The second is pleasure framing, also covered above, and it is the one teams argue with most because the line is a judgment call. If a reviewer could reasonably read the ad as being about sex rather than health care, rework it before you appeal it.

The third is language aimed at the viewer's body. Meta's Health and Wellness standards prohibit ads that contain statements of inferiority about physical appearance, described as terms, descriptions or questions that are negative and attack a person's appearance, specific body parts or hygiene. Hooks that address how the viewer looks, rather than what she is experiencing with her prescription, run into this rule quickly.

The fourth is a prescription ad from an advertiser that is not certified, or an ad targeted outside the countries where the advertiser is certified. The fifth is a health claim the brand cannot support. An effectiveness figure, a promise about pregnancy prevention, or a statement that a method has no side effects is a health claim, and it carries its own review and legal risk. That risk is large enough to deserve its own treatment, separate from the platform rules covered here.

What the July 2026 Revision Changed

Meta's Health and Wellness page carries a change log entry dated July 23, 2026. The entry has no description attached, and the policy page states the current rules without comparing them to the previous version. Meta's own text, in other words, does not say what changed.

Marketing agency write-ups published around the update describe the revision as a move from judging an ad by its product category to judging it by the claims it makes. They also report that before and after imagery is no longer rejected on sight. The write-ups we reviewed do not link to a Meta source for those points, so treat them as reported rather than confirmed until Meta publishes detail.

What the current text does confirm matters more for a contraception brand. Contraceptive products and family planning methods, including fertility awareness, are named as allowed examples. The 18 and over requirement is in the text. The health versus pleasure focus test is in the text. Prescription reproductive health drugs are still routed to the Drugs and Pharmaceuticals policy, with its certification, country and age requirements.

If the reported shift to claims-based review holds, the words in the ad carry more of the weight and the product label carries less. For birth control that cuts both ways. A well-framed ad for an allowed product should face less friction from category flags. A careless claim in the voiceover or on a caption card becomes the more likely reason for a rejection.

Building Ads That Clear Review

Run every birth control ad through the same order of checks before it goes live. Start with the age range on every ad set. Then read every hook, caption and visual for pleasure framing, and ask whether a stranger would describe the ad as being about health care. Then read for statements aimed at the viewer's appearance. Then check every health claim, spoken or written, against what the brand can substantiate. Finally, for prescription products, confirm certification status and country targeting.

Keep your own record of what was approved, what was rejected and the reason Meta gave. Meta's policy pages change without detailed notes, as the July entry shows, so an internal log is often the clearest picture of how the rules are being applied to your account right now. It also gives you something concrete to point to when you request a manual review.

Treat repeated rejections as an account risk, not a creative inconvenience. A pattern of rejected ads can put the whole account under restriction, which our piece on why telehealth ad accounts get flagged on Meta explains in more detail. For the wider policy that sits around all of this, see Meta's Health and Wellness ad policy explained for telehealth.

The Short Version

Meta names contraception as an allowed category. Every ad must be targeted to people 18 and over and must focus on health rather than sexual pleasure. Prescription contraception also needs LegitScript certification and eligible country targeting under the Drugs and Pharmaceuticals policy. The July 2026 revision is logged but not described by Meta, and the reported move to claims-based review puts more weight on the words in the ad. Get the setup right, keep the frame on health care, and keep claims inside what the brand can support.